Percheron Therapeutics clears HMBD-002 manufacturing milestone ahead of new cancer drug trial
The company is on track to prepare clinical trial material for a planned new study in the second half of CY2026.
Coverage
57609 stories · page 63 of 2881
The company is on track to prepare clinical trial material for a planned new study in the second half of CY2026.